Dead-end pages

Jump to navigation Jump to search

The following pages do not link to other pages in QIBA Wiki.

Showing below up to 50 results in range #1 to #50.

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)

  1. 2012 Call Summaries
  2. 2013 Call Summaries
  3. 2014 Call Summaries
  4. 2015 Call Summaries
  5. 2016 Call Summaries
  6. 2019
  7. 2020
  8. 2021
  9. ASFNR Materials - Abstract for Review
  10. ASL Meeting Summaries Archive
  11. About QIBA
  12. Additional letters of support can be found here
  13. Agenda from 02.17.2012 FDG-PET Tech Committee Call
  14. Alzheimer's Disease PET Archive
  15. Ambition Levels for Collaboration
  16. Archive
  17. Archive - Lung Density
  18. Archived: 2009 COPD/Asthma Call Summaries
  19. Archived: 2010 - 2011 fMRI Reproducibility Call Summaries
  20. Archived: 2010 COPD/Asthma Call Summaries
  21. Archived: 2011 COPD/Asthma Call Summaries
  22. Archived: 2011 CT Volumetry - Group 3A Call Summaries
  23. Archived: 2012 CT Volumetry - Group 3A Call Summaries
  24. Archived: 2012 QIBA US SWS Technical Committee call summaries
  25. Archived: 2012 fMRI Reproducibility Call Summaries
  26. Archived: 2013 fMRI Bias WG Call Summaries
  27. Archived: 2014 fMRI Bias WG Call Summaries
  28. Archived: 2016 Lung Density BC Call Summaries
  29. Archived: fMRI Bias WG Call Summaries
  30. Archived: fMRI Reproducibility Call Summaries
  31. Archived "What is a Profile?" description as of 08.19.2011
  32. Archived - 2010-2011 fMRI Reproducibility Call Summaries
  33. Archived - 2011 fMRI Reproducibility Call Summaries
  34. Archived DCE-MRI Profiles
  35. Archived Versions of QIBA Vol CT - Group 3A draft documents
  36. Atherosclerosis Biomarkers Profile Draft Archive
  37. CEUS BC Call Summaries
  38. CEUS Task Force (TF) Call Summaries
  39. COPD Group Call Summaries
  40. CTV-AD Considerations for Future Editions
  41. CT Acquisition Protocol Groundwork
  42. CT Angiography Call Summaries Archive
  43. CT Angiography Profile Draft Archive
  44. CT Draft Proffered Protocols
  45. Call Agenda Topics
  46. Claim Language/Detail
  47. Clinical Applications and Biological Targets Subcommittee
  48. Clinical Sites
  49. Clinical Trial Planning
  50. Clinical Trials Collaboration

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)